GenoME Pipeline
The pipeline identifies novel DNA methylation changes directly from liquid biopsies or tissue samples.
GenoME machine learning analysis incorporates novel fragmentomics to ensure biomarkers are highly sensitive and disease-specific.
GenoME identifies high potential biomarkers, evaluated in a highly optimised PCR pipeline, combines the highest performing markers into a single test measured on cutting edge digital PCR.
Digital PCR is highly sensitive and specific, high-throughput, cost-effective and user friendly. GenoME pipeline can additionally repurpose existing NGS data to identify innovative biomarkers for multiple uses.
We will be continuing innovative development both in house, and through partnership and collaboration.